PASG
Passage BIO, Inc.Company Information
- Company Name
- Passage BIO, Inc.
- CIK
- CIK0001787297
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- PASG: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2836
- SIC Description
- Biological Products, (No Diagnostic Substances)
- Ticker
- PASG
SEC filing data through
Insider Sentiment
- Last purchase
- 2026-06-25
- Last sale
- 2026-01-08
- Shares purchased (TTM)
- 128,378
- Shares sold (TTM)
- 219,395
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 4,249,126
- Shares outstanding
- 3,208,744
- Ownership
- 132.42%
Earnings Market Reaction
- Filing date
- 2026-08-10
- Price on filing date
- —
- 1-month reaction
- 7.64%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 24 | 33 | 46 | 53 | 58 | 63 | 38 | 32 | 25 | 37 | 22 | 34 | ||||||
| Prepaid Expense And Other Assets Current | 1 | 1 | 1 | 2 | 1 | 2 | 1 | 1 | 1 | 2 | 1 | 1 | ||||||
| Available For Sale Securities Debt Securities Current | - | 0 | 0 | 0 | 0 | - | 39 | 53 | 67 | 68 | 93 | 99 | ||||||
| Assets Current | 25 | 35 | 48 | 56 | 60 | 67 | 79 | 87 | 95 | 108 | 118 | 136 | ||||||
| Property Plant And Equipment Net | - | 1 | 4 | 5 | 5 | 6 | 9 | 10 | 13 | 14 | 15 | 16 | ||||||
| Operating Lease Right Of Use Asset | - | 1 | 10 | 13 | 13 | 14 | 14 | 14 | 17 | 17 | 17 | 17 | ||||||
| Other Assets Noncurrent | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | ||||||
| Assets | 25 | 36 | 62 | 74 | 79 | 86 | 102 | 112 | 125 | 141 | 151 | 169 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 2 | 1 | 3 | ||||||
| Contract With Customer Liability Current | 16 | 14 | 14 | 14 | 10 | 9 | 8 | 5 | - | - | - | - | ||||||
| Operating Lease Liability Current | - | 1 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 3 | 3 | ||||||
| Liabilities Current | 21 | 20 | 23 | 22 | 20 | 18 | 19 | 17 | 12 | 13 | 16 | 20 | ||||||
| Operating Lease Liability Noncurrent | - | 5 | 20 | 21 | 21 | 21 | 22 | 22 | 22 | 23 | 23 | 23 | ||||||
| Liabilities | 21 | 25 | 44 | 43 | 41 | 39 | 41 | 39 | 35 | 36 | 39 | 43 | ||||||
Stockholders Equity | ||||||||||||||||||
| Common Stock Value | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | - | - | - | - | - | - | 0 | 0 | -0 | -0 | -0 | -0 | ||||||
| Additional Paid In Capital | 725 | 724 | 724 | 723 | 722 | 721 | 720 | 719 | 718 | 716 | 706 | 704 | ||||||
| Retained Earnings Accumulated Deficit | -720 | -712 | -705 | -692 | -684 | -675 | -659 | -647 | -627 | -611 | -594 | -578 | ||||||
| Stockholders Equity | 4 | 12 | 19 | 31 | 38 | 47 | 61 | 73 | 91 | 105 | 111 | 126 | ||||||
| Liabilities And Stockholders Equity | 25 | 36 | 62 | 74 | 79 | 86 | 102 | 112 | 125 | 141 | 151 | 169 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | ||||||
| Preferred Stock Shares Authorized | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | - | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | ||||||
| Common Stock Shares Issued | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | ||||||
| Shares Outstanding | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialPassage BIO, Inc. (PASG) — SEC Financial Statements & Analysis
Passage BIO, Inc. (PASG) is a biological products, (no diagnostic substances) company, incorporated in DE. Passage BIO, Inc. trades on Nasdaq as: PASG. Passage BIO, Inc. (PASG)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-10. Based on that filing, Passage BIO, Inc. carries a market cap of $15.66M, a P/E ratio of -0.43x, a P/B ratio of 3.51x, an enterprise value of $-8.50M, and an EV/EBITDA multiple of 0.22x. On profitability, it posts a Return on Equity (ROE) of -169.09%, a Return on Assets (ROA) of -69.20%, and a Return on Invested Capital (ROIC) of -124.31%. Per share, it reports EPS of $-11.25, diluted EPS of $-11.25, free cash flow per share of $-10.44, and a dividend per share of $0.00. Over the trailing year, it posted net income growth of -36.48% year-over-year and EPS growth of -37.27% year-over-year. On the balance sheet, it maintains a current ratio of 1.22x, a quick ratio of 1.18x, working capital of $4.46M, a debt-to-equity ratio of 4.65x, a debt ratio of 0.82, free cash flow of $-33.50M (TTM), and net debt of $-24.16M. Figures sourced from SEC EDGAR.
- Market Cap
- $15.66M
- P/E TTM
- -0.43x
- EPS TTM
- $-11.25
- P/B TTM
- 3.51x
- ROE TTM
- -169.09%
- ROA TTM
- -69.20%
- Debt To Equity
- 4.65x
- Free Cash Flow TTM
- $-33.50M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Passage BIO, Inc. in?
Passage BIO, Inc. (PASG) operates in the Biological Products, (No Diagnostic Substances) industry.
What exchange does PASG trade on?
Passage BIO, Inc. (PASG) trades on the Nasdaq.
Where is Passage BIO, Inc. incorporated?
Passage BIO, Inc. is incorporated in DE.
When was Passage BIO, Inc. (PASG)'s most recent SEC filing?
Passage BIO, Inc. (PASG)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-10.
What is PASG's market cap?
Passage BIO, Inc. (PASG) has a market capitalization of $15.66M as of 2026-06-30.
What is PASG's EPS (earnings per share)?
Passage BIO, Inc. (PASG)'s trailing twelve month EPS is $-11.25 as of 2026-06-30.
What is PASG's ROE (return on equity)?
Passage BIO, Inc. (PASG)'s trailing twelve month Return on Equity (ROE) is -169.09% as of 2026-06-30.
What is PASG's ROA (return on assets)?
Passage BIO, Inc. (PASG)'s trailing twelve month Return on Assets (ROA) is -69.20% as of 2026-06-30.
What is PASG's ROIC (return on invested capital)?
Passage BIO, Inc. (PASG)'s trailing twelve month Return on Invested Capital (ROIC) is -124.31% as of 2024-12-31.
What is PASG's EV/EBITDA?
Passage BIO, Inc. (PASG)'s trailing twelve month EV/EBITDA is 0.22x as of 2026-06-30.